T-lymphocyte activation and the levels of eosinophilic cationic protein and interleukin-5 in asthmatic children with acute exacerbation and effect of glucocorticoid treatment

Allergy and Asthma Proceedings

Volumn 27, Issue 4, 2006, Pages 371-377

  Kocak, A Kadir ^a,b   Bor, Ozcan ^a,b   Yildiz, Bilal ^a,b   Erdogan, Levent ^a,b   Us, Tercan ^a,b  

^a Osmangazi University ^*

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; PREDNISOLONE; RNASE3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; ASTHMA; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CHILD; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; LUNG FUNCTION TEST; MALE;

ADOLESCENT; ASTHMA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHILD; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-5; MALE; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; RESPIRATORY FUNCTION TESTS;

EID: 33748116884     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2885     Document Type: Article

References (23)

1. 4 T-lymphocyte activation is associated with peak expiratory flow variability in childhood asthma. J Allergy Clin Immunol 97:955-962, 1996.
2. Gemou-Engesaeth V, Fagerhol MK, Toda M, et al. Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: Effect of inhaled glucocorticoid therapy. Pediatrics 109:E24, 2002.
3. Douglas SR, Qutayba H, Sun Y, et al. Predominant Th2-like broncoalveolar T lymphocyte population in atopic asthma. N Engl J Med 326:298-304, 1992.
4. Corrigan CJ, Hertnell A, and Kay AB. T lymphocyte activation in acute severe asthma. Lancet 1:1129-1132, 1988.
5. Majori M, Piccoli ML, Meloj R, et al. Lymphocyte activation markers in peripheral blood before and after natural exposure to allergen in asthmatic patient. Respiration 64:45-49, 1996.
6. Flood-Page PT, Menzies-Gow AN, Kay AB, and Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167:199-204, 2003.
7. Gregory B, Kirchem A, Phipps S, et al. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. Immunology 170:5359-5366, 2003.
8. Tavernier J, Van de Heyden J, Verhee A, et al. Interleukin-5 regulates the isoform expression of its own receptor α-subunit. Blood 95:1600-1607, 2000.
9. El-Rahdi AS, Hogg CL, Bungre JK, et al. Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma. Arch Dis Child 83:158-162, 2000.
10. Adelroth E, Rosenhell L, Johonsson S, et al. Inflammatory cells and eosinophil activity in asthmatic investigated by BAL. Am Rev Respir Dis 142:90-99, 1998.
11. Walker C, Wirchow JC, Peter LB, et al. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146:1829-1835, 1991.
12. 4 T lymphocyte activation in asthma is accompanied by increased serum concentrations of IL-5. Am Rev Respir Dis 147:540-547, 1993.
13. Lopez AF, Santerson CJ, Gamble JR, et al. Recombinant human IL-5, is a selective activator of human eosinophil function. J Exp Med 167:219-224, 1988.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obtructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225-224, 1987.
15. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Quick reference for the NAEPP Expert Panel Report: Guidelines for the diagnosis and management of asthma. Publication 02-5075, update on selected topics,. US Department of Health and Human Services, National Institutes of Health, Bethesda MD, 2002.
16. Kim CK, Kim SW, Park CS, et al. Bronchoalveolar lavage cytokine profiles in acute asthma and acute bronchiolitis. J Allergy Clin Immunol 112:64-71, 2003.
17. + T lenfosit düzeyleri [in Turkish], Osmangazi Universitesi Tip Fakültesi Dergisi 21:67-73, 1999.
18. Corrigan CJ, and Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Am Rev Respir Dis 141:970-977, 1990.
19. Robinson DS, Larche M, and Durham SR. Tregs and allergic disease. J Clin Invest 114:1389-1397, 2004.
20. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886, 2003.
21. Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425-1433, 2004.
22. 8 T lymphocyte activation in peripheral blood of patients with asthma. J Allergy Clin Immunol 100:379-382, 1997.
23. Wirchow JC Jr, Oehling A, Boer L, et al. Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: A longitudinal study in bronchial asthma. J Allergy Clin Immunol 94:240-249, 1994.